Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001628280-22-025553
Filing Date
2022-09-27
Accepted
2022-09-27 16:03:41
Documents
17
Period of Report
2022-07-12
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A bvs-20220712.htm   iXBRL 8-K/A 43139
2 EX-23.1 exhibit231pwcconsent.htm EX-23.1 2948
3 EX-99.1 exhibit991-september2022ca.htm EX-99.1 501376
4 EX-99.2 exhibit992bvscartihealprof.htm EX-99.2 488906
8 image_3.jpg GRAPHIC 1911
9 image_4.jpg GRAPHIC 1105
  Complete submission text file 0001628280-22-025553.txt   1273233

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bvs-20220712.xsd EX-101.SCH 1902
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bvs-20220712_lab.xml EX-101.LAB 25848
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bvs-20220712_pre.xml EX-101.PRE 13582
11 EXTRACTED XBRL INSTANCE DOCUMENT bvs-20220712_htm.xml XML 11467
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

EIN.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37844 | Film No.: 221271113
SIC: 3841 Surgical & Medical Instruments & Apparatus